Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Amy on +44 1494 818052 or amyp@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Amy Pearce
Account Manager
amyp@zenopa.com
+44 1494 818052

Testimonials
Zenopa helps their candidates in a very professional way in order to further develop their careers. With Zenopa helping me in every step of the recruitment process and in providing guidance in answeri...
William, 2012

Grenier Bio-One launch new safety needle

9 July 2012 14:47 in Scientific Company News


Grenier Bio-One has launched a new piece of medical equipment, the Vacuette Premium Safety Needle System, that it claims will work closely with the EU's new guidelines for the prevention of injury when using sharp objects in the healthcare sector.

The company described its new development as "a passive safety product of the newest generation", noting that it is especially useful because its safety mechanism is engaged at all times and does not need to be turned on by the user.

This reduces the risk of practitioners hurting themselves or their patients with the device before activating its needle-protecting cap.

Furthermore, Grenier Bio-One claimed that the special shape of the needle reduces the stress endured by patients during difficult procedures such as venipuncture.

Its safety mechanism makes it especially suitable for patients at risk of suffering from an infection, concluded the firm.

This comes after Novo Nordisk won the red dot Best of the Best prize for 2012 for its unique insulin injection pen the NovoPen 5.ADNFCR-8000103-ID-801403260-ADNFCR

Other news stories from 09/07/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd